RadNet EBITDA 2010-2024 | RDNT

RadNet ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
RadNet Annual EBITDA
(Millions of US $)
2023 $295
2022 $237
2021 $260
2020 $198
2019 $222
2018 $108
2017 $120
2016 $110
2015 $105
2014 $118
2013 $107
2012 $111
2011 $115
2010 $101
2009 $106
RadNet Quarterly EBITDA
(Millions of US $)
2024-03-31 $60
2023-12-31 $72
2023-09-30 $93
2023-06-30 $74
2023-03-31 $55
2022-12-31 $71
2022-09-30 $55
2022-06-30 $67
2022-03-31 $44
2021-12-31 $50
2021-09-30 $78
2021-06-30 $72
2021-03-31 $60
2020-12-31 $63
2020-09-30 $64
2020-06-30 $40
2020-03-31 $31
2019-12-31 $62
2019-09-30 $55
2019-06-30 $60
2019-03-31 $44
2018-12-31 $20
2018-09-30 $35
2018-06-30 $35
2018-03-31 $18
2017-12-31 $36
2017-09-30 $29
2017-06-30 $32
2017-03-31 $24
2016-12-31 $33
2016-09-30 $31
2016-06-30 $25
2016-03-31 $21
2015-12-31 $29
2015-09-30 $33
2015-06-30 $29
2015-03-31 $15
2014-12-31 $30
2014-09-30 $31
2014-06-30 $34
2014-03-31 $23
2013-12-31 $27
2013-09-30 $26
2013-06-30 $30
2013-03-31 $24
2012-12-31 $23
2012-09-30 $29
2012-06-30 $32
2012-03-31 $28
2011-12-31 $32
2011-09-30 $27
2011-06-30 $32
2011-03-31 $24
2010-12-31 $31
2010-09-30 $26
2010-06-30 $26
2010-03-31 $19
2009-12-31 $37
2009-09-30 $23
2009-06-30 $23
2009-03-31 $23
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.353B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.800B 0.00
Quest Diagnostics (DGX) United States $15.206B 15.72
DaVita (DVA) United States $12.153B 15.10
Encompass Health (EHC) United States $8.638B 22.11
Chemed (CHE) United States $8.214B 25.46
Elanco Animal Health (ELAN) United States $7.131B 18.50
Option Care Health (OPCH) United States $4.815B 18.22
Amedisys (AMED) United States $3.000B 21.25
Astrana Health (ASTH) United States $2.272B 30.73
Addus HomeCare (ADUS) United States $1.901B 27.19
LifeStance Health (LFST) United States $1.877B 0.00
U.S Physical Therapy (USPH) United States $1.393B 37.27
Pennant (PNTG) United States $0.697B 36.81
Aveanna Healthcare Holdings (AVAH) United States $0.531B 0.00
Atai Life Sciences (ATAI) Germany $0.223B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.020B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Novo Integrated Sciences (NVOS) United States $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00